Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elekta AB ( ($SE:EKTA.B) ) has provided an update.
Elekta is set to present its first quarter 2025/26 results on August 28, with a live webcast and Q&A session led by Acting President and CEO Jonas Bolander and CFO Tobias Hägglöv. This presentation could provide insights into Elekta’s operational strategies and financial health, impacting stakeholders and market positioning.
The most recent analyst rating on ($SE:EKTA.B) stock is a Sell with a SEK71.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta is a leader in precision radiation therapy, dedicated to providing the best cancer care through sustainable, outcome-driven, and cost-efficient solutions. Headquartered in Stockholm, Sweden, and listed on Nasdaq Stockholm, Elekta collaborates globally with over 4,500 employees to advance cancer care technology.
Average Trading Volume: 1,167,459
Technical Sentiment Signal: Sell
Current Market Cap: SEK17.9B
Learn more about EKTA.B stock on TipRanks’ Stock Analysis page.